U.S. Marijuana Stocks to Watch as Legalization Gains Traction
The U.S. cannabis industry continues to show strong momentum as investors look for opportunities in top marijuana stocks. The market generated over $33 billion in sales during 2024, making it one of the fastest-growing consumer sectors. Furthermore, analysts project annual sales could surpass $56 billion by 2030. Recent headlines have focused on federal rescheduling efforts, which could ease tax burdens for cannabis companies. Additionally, more states are preparing adult-use legalization measures, increasing growth opportunities for multi-state operators. These developments highlight the importance of tracking leading U.S. cannabis stocks. However, investors must carefully evaluate fundamentals and sector catalysts. As legalization expands, volatility is likely to remain a constant factor.
Therefore, technical analysis becomes a key tool for navigating this fast-moving sector. Traders often watch support and resistance levels to identify potential entry points. Moving averages also help confirm momentum shifts and the direction of trends. Moreover, volume patterns can signal strength behind stock moves. Combining these tools with strict risk management is crucial. Using stop losses can help minimize downside risk in volatile sessions. Scaling into positions gradually also helps balance exposure. Since cannabis stocks can swing sharply, proper position sizing is essential. With discipline, investors can manage risk while seeking to maximize returns. Ultimately, combining technical setups with industry growth drivers creates a balanced trading approach. This week, several marijuana stocks stand out for close monitoring.
[Read More] September 2025 Cannabis Stock Picks: Ancillary Market Leaders
3 Top U.S. Marijuana Stocks to Watch Before October 2025
- Green Thumb Industries (OTC: GTBIF)
- Glass House Brands (OTC: GLASF)
- Cresco Labs (OTC: CRLBF)
Green Thumb Industries (OTC: GTBIF)
Green Thumb Industries is one of the largest U.S. cannabis operators. The company manages a diverse portfolio of retail brands. These include RISE Dispensaries and popular product lines such as RYTHM and Dogwalkers. Green Thumb has expanded into 14 states, focusing on high-demand, limited-license markets. This approach has allowed it to capture strong market share in Illinois and Pennsylvania. The company currently operates over 100 dispensaries nationwide. Management recently confirmed 108 locations, with steady growth in core markets. Green Thumb’s retail footprint provides broad consumer access and brand visibility. With a disciplined expansion plan, the company has maintained leadership in multiple regions. Overall, it stands out as a balanced operator with scale, innovation, and proven execution.
Financially, Green Thumb has shown consistent growth in 2025. The company reported quarterly revenue of approximately $293 million. This result reflected a year-over-year increase despite ongoing price compression. Adjusted EBITDA was around $83 million, maintaining strong 28% margins. Operating cash flow reached $56 million during the quarter. This allowed Green Thumb to support investments and share buybacks. In fact, the company recently repurchased approximately 5.6 million shares. Its balance sheet carried $177 million in cash, highlighting financial flexibility. Management emphasized continued gains in competitive markets. Pricing pressure remains a challenge, yet profitability has held steady. Cost control and efficiency supported results across product categories. With progress on rescheduling and adult-use rollouts ahead, Green Thumb remains well-positioned. The company’s strong fundamentals and disciplined strategy make it a stock to watch closely in the lead-up to October.
[Read More] Best Cannabis Stocks in Canada to Watch Now: Technical Signals and Market Outlook
Glass House Brands (OTC: GLASF)
Glass House Brands has built its reputation as a California-focused cannabis company. It is recognized for large-scale greenhouse cultivation and efficient production. The company’s brands include Glass House Farms and PLUS, both popular with California consumers. Its retail network operates under banners like Farmacy, NHC, and The Pottery. Glass House currently manages 10 dispensaries across the state. This network supports its vertically integrated model. By controlling cultivation and retail, the company reduces costs and captures more margin. California is the largest cannabis market in the U.S. Therefore, Glass House focuses entirely on that region. The strategy emphasizes low-cost production and high-volume sales. This unique positioning makes it an attractive play on California’s long-term growth.
Financially, Glass House delivered strong results in 2025. In the second quarter, revenue was $59.9 million, up 11% year over year. Gross margins expanded to 53%, showing efficiency improvements. Adjusted EBITDA came in at $18.1 million. Operating cash flow was positive at $17.7 million, signaling healthy fundamentals. Cash reserves, including restricted cash, stood at $44.2 million. Cultivation volume was impressive at 231,000 pounds during the quarter. Costs improved significantly, averaging only $91 per pound. Management adjusted Q3 production guidance due to temporary labor constraints. However, production is expected to rebound strongly in Q4. Even with revised guidance, operational efficiency remains a highlight. With its scale and low-cost cultivation advantage, Glass House is positioned for resilience. For investors seeking targeted California exposure, it remains a strong candidate before October.
[Read More] Best Canadian Marijuana Stocks for Traders and Investors Right Now
Cresco Labs (OTC: CRLBF)
Cresco Labs is a major U.S. cannabis operator with a dual focus on retail and wholesale. Its Sunnyside retail brand has gained significant recognition. The company has prioritized strong brand development across flower, concentrates, and edibles. Cresco’s footprint covers multiple core states, including Illinois and Pennsylvania. It also continues to expand in Ohio, where adult-use growth presents new opportunities. As of September 2025, Cresco operated 71 Sunnyside dispensaries nationwide. Its most recent opening was in Proctorville, Ohio, with more expected soon. This retail base drives customer loyalty while supporting wholesale distribution. Cresco’s balanced model allows it to scale efficiently while defending margins. The company’s nationwide reach makes it a key player in the evolving U.S. market.
Financially, Cresco posted revenue of $164 million in the second quarter of 2025. Adjusted gross margin was 50.6%, highlighting strong cost management. Adjusted EBITDA was approximately $41 million. Operating cash flow came in at $9 million for the quarter. The company reported a net loss of $14 million, primarily from non-cash impairments. However, expense control has been effective. Selling, general, and administrative expenses were 31% of revenue, reflecting discipline. Cresco also took steps to refinance debt, improving financial flexibility. Management emphasized opportunities from Ohio’s transition to adult-use sales. Additionally, federal rescheduling could significantly reduce tax burdens. The company continues to optimize its asset portfolio for profitability. With 71 dispensaries and a robust wholesale platform, Cresco is well-positioned to capitalize on upcoming catalysts. Investors should closely monitor Cresco as it balances efficiency and expansion.
Investors Watching the Market This Week
Each of these cannabis companies offers unique strengths. Green Thumb combines scale and consistent profitability. Glass House delivers unmatched California exposure with low-cost cultivation. Cresco balances retail and wholesale with disciplined operations. Together, they represent three strong ways to gain exposure to U.S. cannabis before October 2025. Investors should also apply technical analysis for better entries. Monitoring support, resistance, and moving averages can improve timing. Risk management is essential given sector volatility. By scaling positions carefully, traders can minimize downside risk. With catalysts like rescheduling and new state launches approaching, these three stocks are worth keeping on watchlists.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
